Annika de Jong

554 total citations
16 papers, 294 citations indexed

About

Annika de Jong is a scholar working on Hematology, Surgery and Molecular Biology. According to data from OpenAlex, Annika de Jong has authored 16 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 4 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Annika de Jong's work include Platelet Disorders and Treatments (8 papers), Blood groups and transfusion (5 papers) and Cell Adhesion Molecules Research (4 papers). Annika de Jong is often cited by papers focused on Platelet Disorders and Treatments (8 papers), Blood groups and transfusion (5 papers) and Cell Adhesion Molecules Research (4 papers). Annika de Jong collaborates with scholars based in Netherlands, United States and Canada. Annika de Jong's co-authors include Jeroen Eikenboom, Richard Dirven, Bart J.M. van Vlijmen, Yvonne D. Krom, Peter Thijssen, Patrick J. van der Vliet, Marlinde L. van den Boogaard, Judit Balog, Kirsten R. Straasheijm and Silvère M. van der Maarel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Annals of the Rheumatic Diseases and Thrombosis and Haemostasis.

In The Last Decade

Annika de Jong

15 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Annika de Jong Netherlands	9	158	120	49	46	43	16	294
Myrto Kostadima United Kingdom	5	147 0.9×	76 0.6×	12 0.2×	23 0.5×	37 0.9×	7	245
Alexandre Guy France	9	143 0.9×	113 0.9×	20 0.4×	22 0.5×	166 3.9×	27	287
T J Kunicki United States	7	288 1.8×	51 0.4×	35 0.7×	23 0.5×	34 0.8×	9	335
Fabien Pertuy France	7	216 1.4×	60 0.5×	26 0.5×	22 0.5×	69 1.6×	9	311
Estelle Carminita United States	6	65 0.4×	77 0.6×	20 0.4×	19 0.4×	15 0.3×	12	238
RC Johnson United States	3	145 0.9×	68 0.6×	26 0.5×	42 0.9×	32 0.7×	4	335
Serena Barozzi Italy	11	245 1.6×	61 0.5×	14 0.3×	15 0.3×	79 1.8×	19	325
Keita Horitani Japan	9	201 1.3×	107 0.9×	16 0.3×	63 1.4×	120 2.8×	20	359
Chacko Joseph Australia	6	102 0.6×	135 1.1×	73 1.5×	17 0.4×	59 1.4×	9	295
Javier Martín-Ramírez Netherlands	7	45 0.3×	148 1.2×	32 0.7×	10 0.2×	47 1.1×	9	322

Countries citing papers authored by Annika de Jong

Since Specialization

Citations

This map shows the geographic impact of Annika de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annika de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annika de Jong more than expected).

Fields of papers citing papers by Annika de Jong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annika de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annika de Jong. The network helps show where Annika de Jong may publish in the future.

Co-authorship network of co-authors of Annika de Jong

This figure shows the co-authorship network connecting the top 25 collaborators of Annika de Jong. A scholar is included among the top collaborators of Annika de Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annika de Jong. Annika de Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Echeverri, Elisa Schrader, Richard Dirven, Kalina Paunovska, et al.. (2023). Small interfering RNA–mediated allele-selective silencing of von Willebrand factor in vitro and in vivo. Blood Advances. 7(20). 6108–6119. 14 indexed citations

Peyron, Ivan, Serge Pierre‐Louis, Pierre Boisseau, et al.. (2022). Identification of von Willebrand factor D4 domain mutations in patients of Afro‐Caribbean descent: In vitro characterization. Research and Practice in Thrombosis and Haemostasis. 6(4). e12737–e12737. 2 indexed citations

Solingen, Coen van, Maren de Vries, Tessa J. Barrett, et al.. (2022). Long noncoding RNA CHROMR regulates antiviral immunity in humans. Proceedings of the National Academy of Sciences. 119(37). e2210321119–e2210321119. 33 indexed citations

Bowman, Mackenzie, Colleen Notley, Patrícia Lima, et al.. (2020). Endothelial characteristics in healthy endothelial colony forming cells; generating a robust and valid ex vivo model for vascular disease. Journal of Thrombosis and Haemostasis. 18(10). 2721–2731. 20 indexed citations

Jong, Annika de, Richard Dirven, Lisa D.S. Bloomer, et al.. (2020). Characterization of large in-frame von Willebrand factor deletions highlights differing pathogenic mechanisms. Blood Advances. 4(13). 2979–2990. 7 indexed citations

Jong, Annika de, Richard Dirven, Johan Boender, et al.. (2020). Ex vivo Improvement of a von Willebrand Disease Type 2A Phenotype Using an Allele-Specific Small-Interfering RNA. Thrombosis and Haemostasis. 120(11). 1569–1579. 22 indexed citations

Jong, Annika de, et al.. (2019). Variability of von Willebrand factor‐related parameters in endothelial colony forming cells. Journal of Thrombosis and Haemostasis. 17(9). 1544–1554. 17 indexed citations

Heestermans, Marco, Annika de Jong, Pieter H. Reitsma, et al.. (2019). Use of “C9/11 Mismatch” Control siRNA Reveals Sequence-Related Off-Target Effect on Coagulation of an siRNA Targeting Mouse Coagulation Factor XII. Nucleic Acid Therapeutics. 29(4). 218–223. 2 indexed citations

Heestermans, Marco, et al.. (2019). Use of "C9/11 Mismatch" Control Small Interfering RNA Reveals Sequence-Related Off-Target Effect on Coagulation of an Small Interfering RNA Targeting Mouse Coagulation Factor XII. Nucleic Acid Therapeutics. 1–6. 1 indexed citations

10.

Jong, Annika de, et al.. (2018). Correction of a dominant‐negative von Willebrand factor multimerization defect by small interfering RNA‐mediated allele‐specific inhibition of mutant von Willebrand factor. Journal of Thrombosis and Haemostasis. 16(7). 1357–1368. 19 indexed citations

11.

Jong, Annika de & Jeroen Eikenboom. (2017). Von Willebrand disease mutation spectrum and associated mutation mechanisms. Thrombosis Research. 159. 65–75. 49 indexed citations

12.

Jong, Annika de & Jeroen Eikenboom. (2015). Developments in the diagnostic procedures for von Willebrand disease. Journal of Thrombosis and Haemostasis. 14(3). 449–460. 46 indexed citations

13.

Balog, Judit, Peter Thijssen, Sean Shadle, et al.. (2015). Increased DUX4 expression during muscle differentiation correlates with decreased SMCHD1 protein levels at D4Z4. Epigenetics. 10(12). 1133–1142. 55 indexed citations

14.

Jong, Annika de, et al.. (2014). OP0219 T Cells in the Infrapatellar FAT PAD of Osteoarthritis Patients as A Source of IL-6 in the Joint. Annals of the Rheumatic Diseases. 73. 145–145. 1 indexed citations

15.

Janssen, M., et al.. (2006). Reduced life expectancy in RA patients in a community rheumatology practice in the Netherlands. Annals of the Rheumatic Diseases. 65. 89–89.

16.

Kuipers, Ernst J. & Annika de Jong. (1990). [Gastrointestinal disorders and Streptococcus bovis bacteremia].. PubMed. 134(28). 1337–9. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact